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Background: The permanent down-regulated expression of T-cell intracellular antigen (TIA) proteins in HeLa cells
improves cytoskeleton-mediated functions such as cell proliferation and tumor growth.
Methods: Making use of human and mouse cells with knocked down/out expression of T-cell intracellular antigen
1 (TIA1) and/or TIA1 related/like (TIAR/TIAL1) proteins and classical RNA (e.g. reverse transcription-quantitative
polymerase chain reaction, polysomal profiling analysis using sucrose gradients, immunoblotting, immunoprecipitation,
electrophoretic mobility shift assays, ultraviolet light crosslinking and poly (A+) test analysis) and cellular (e.g.
immunofluorescence microscopy and quimeric mRNA transfections) biology methods, we have analyzed the regulatory
role of TIA proteins in the post-transcriptional modulation of beta-actin (ACTB) mRNA.
Results: Our observations show that the acquisition of above cellular capacities is concomitant with increased
expression levels of the actin beta subunit (ACTB) protein. Regulating TIA abundance does not modify ACTB mRNA
levels, however, an increase of ACTB mRNA translation is observed. This regulatory capacity of TIA proteins is linked to
the ACTB mRNA 3′-untranslated region (3′-UTR), where these proteins could function as RNA binding proteins. The
expression of GFP from a chimeric reporter containing human ΑCΤΒ 3′-UTR recapitulates the translational control
found by the endogenous ACTB mRNA in the absence of TIA proteins. Additionally, murine embryonic fibroblasts
(MEF) knocked out for TIA1 rise mouse ACTB protein expression compared to the controls. Once again steady-state
levels of mouse ACTB mRNA remained unchanged.
Conclusions: Collectively, these results suggest that TIA proteins can function as long-term regulators of the ACTB
mRNA metabolism in mouse and human cells.
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Gene expression in higher eukaryotes is a multilayer
process involving several complex processes, such as the
transcription, splicing, translation and turnover of RNAs
and proteins. It is now well-established that each step of
this informative circuit is modulated by gene-regulatory
events. So far each individual process has been strongly
studied, but little is known about how the combined effect
of all regulatory events shapes gene expression by multi-
functional proteins. Thus, the fundamental question of
how genomic and transcriptomic information is processed
at different levels in response to dynamic regulatory* Correspondence: jmizquierdo@cbm.uam.es
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article, unless otherwise stated.changes and environmental stresses to obtain specific
proteome diversity have therefore remained unanswered.
The T-cell intracellular antigen 1 (TIA1) and the
TIA1-related (TIAR) proteins are multifunctional modu-
lators at different layers of the gene expression regula-
tory flux and a good candidates to carry out these
studies. These proteins are essential cellular components
during early development because mice lacking TIA1 or
TIAR as well as over-expressing TIAR, show high rates
of embryonic lethality [1-3]. They can interact with
DNA and RNA polymerase II (RNA pol II) to modulate
the transcriptional rates of genes that encode functional
proteins and RNAs [4-8]. TIA proteins are also splicing
factors regulating around the 10% of pre-mRNAs spli-
cing events occurring in the human genome [9]. These
splicing regulators promote the U1 snRNP recruitmenttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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ternative exons containing introns with U-rich stretches
adjacent to the 5′ splice sites [9-14].
In the cytoplasm, these proteins have dual roles in
promoting stability and/or repressing translation of
mRNAs involved in apoptotic and inflammatory path-
ways [1,8,15-17]. This capacity is associated to their
binding at the 5′ and 3′-untranslated regions (UTRs) of
the mRNAs containing U-, AU- and C-rich sequence
contexts [7,9,18-22]. From a (patho-) physiological view-
point, these regulators have been involved in the devel-
opment of main biological processes and complex
cellular responses, such as apoptosis, inflammation,
virus-mediated infections, environmental stress, embryo-
genesis and tumorigenesis [1-3,8,23-27]. Although the
roles of TIA proteins in key processes as, for example,
inflammation, environmental stress and viral infections
are well established, its effects on cell proliferation and
tumor growth remain elusive.
To shed light on the potential role of TIA proteins in
regulating proliferative responses, we used RNA interfer-
ence strategy to knock down TIA expression in HeLa
cells. We provide evidence that TIA-knocked down
HeLa cells can enhance ACTB protein expression, ac-
companied by the ability to assemble actin stress fibers.
This observation reveals a functional link at long-term
between TIA proteins and the formation and remodeling
of actin-based cytoskeletal structures. Given that TIA
proteins can be associated with ACTB mRNA through
its 3′-UTR, we show that the absence of TIA proteins
facilitates the translation of a chimeric mRNA contain-
ing the 3′-UTR of the human ACTB mRNA. Mouse em-
bryonic fibroblasts knocked out for TIA1 resulted in an
increase in ACTB protein expression. Our observations
suggest that the TIA proteins can play a regulatory role
in post-transcriptional modulation of ACTB mRNA.
Results
Stable silencing of TIA proteins leads to an increase in
expression of β-actin protein
Previous results revealed that the reduction of TIA pro-
teins by stable RNA interference using specific short
hairpin RNAs in HeLa cells triggers cytoskeleton-based
functions, such as cell proliferation, migration and inva-
sion [27]. These cellular phenotypes are ensured by a
solid network of cytoplasmic stress fibers that connect
different points at the cellular edges, leading to the
maintenance of cell-cell or cell-extracellular matrix con-
tacts [28]. Using the TIA-knocked down HeLa cells de-
scribed above ([27] and Additional file 1: Figure S1), we
investigated the effect of the reduction of TIA1 and/or
TIAR proteins on the β-actin expression, a major com-
ponent of cytoskeleton-based functions. HeLa cells were
fixed and processed for indirect immunofluorescencewith specific antibodies against TIA1, TIAR, HuR, β-
actin and α-tubulin proteins, respectively, together with
phalloidin to visualize stress fibers that are represented
by polymerized F-actin proteins (Figure 1 and Additional
file 1: Figure S1). The results of fluorescence intensity
showed that the expression levels of β-actin protein and
stress fibers were increased 2-3-fold in the absence of
TIA1 and/or TIAR proteins (Figure 1A and B). By con-
trast, the expression of β-actin protein and stress fibers
in HeLa cells was slightly down-regulated in the absence
of HuR in agreement with previous data [29]. No signifi-
cant differences were observed for α-tubulin protein ex-
pression between the experimental conditions examined.
Collectively, these observations show the impact of TIA
proteins in β-actin expression.
The knockdown of TIA proteins increases the expression
of β-actin protein without affecting the steady-state level
of its mRNA
It is possible that the role of TIA proteins in cell behav-
ior is mediated by its ability to regulate the metabolism
of β-actin mRNA. As shown in Figure 2, we observed a
significant increase (2-fold) in the levels of β-actin pro-
tein by western blot analysis in TIA1 and TIAR-knocked
down HeLa cells compared to controls (Figure 2A, com-
pare lane 1 with 2 and 3) and the HuR-silenced HeLa
cells (Figure 2A, compare lane 1 with 4). These increases
were not accompanied by similar changes at the steady-
state levels of the β-actin mRNA (Figure 2A). Given that
similar results were obtained with TIA1 plus TIAR-
knocked down HeLa cells (Figure 2B), we concluded
that TIA proteins can regulate the expression of the β-
actin mRNA at the post-transcriptional level. Likewise,
endogenous β-actin mRNA levels in HeLa cells did not
change after stable silencing of TIA proteins, while the
expression of the encoded β-actin protein increased
markedly without apparent changes in β-actin mRNA
stability. These observations suggest that the TIA pro-
teins could be modulating its translation. In this regard,
evidence that TIA proteins modulate translation of
the β-actin mRNA was obtained by polysomal profiling
analysis. Cytoplasmic extracts from control and TIA-
knocked down HeLa cells were fractionated through
sucrose gradient, with the lightest components sedi-
menting at the top (fractions 1 and 2), small (40S) and
large (60S) ribosomal subunits and monosomes (80S) in
fractions 3-6, and progressively larger polysomes in frac-
tions 7-11 (Figure 2C). The distribution of the β-actin
mRNA versus GAPDH mRNA, known as housekeeping
gene, was measured by grouping fractions in free plus
monosomes (FM) (fractions 1-7) and in polysomes (P)
(fractions 8-11). The pools of the RNAs in FM and P
fractions were quantified by semiquantitative reverse
transcription and polymerase chain reaction (RT-PCR)
Figure 1 Stable TIA knockdown leads to an increased expression of beta-actin protein. (A) Exponentially growing HeLa cells stably transfected
with control, TIA1, TIAR, TIA1 plus TIAR (1 + R) and HuR shRNAs were stained with anti-β-actin and anti-α-tubulin antibodies as well as incubated with
phalloidin-TRITC and TO-PRO-3 reagents. The post-stained HeLa cells were visualized by fluorescence microscopy. (B) The fluorescence intensity of
β-actin, phalloidin and α-tubulin were quantified from at least 30 different images per sample using ImageJ software. These quantifications are
represented by histograms where the white, lightgray, darkgray, black and gray bars correspond to the control, TIA1, TIAR, TIA1 plus TIAR (1 + R) and
HuR samples, respectively. The represented values were normalized and expressed relative to control (c), whose value is fixed arbitrarily to 1, and are
means ± SEM (n = 30; *P < 0.05; **P < 0.01). The scale bar shows 8 μm.
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gradient fractions (Figure 2C). The results show an
enrichment of the β-actin/GAPDH ratio (2-fold) in poly-
somes versus free +monosomes fractions in TIA-silenced
HeLa cells. Additional evidence that TIA proteins modu-
lated β-actin translation was gained from nascent transla-
tion analysis. We determined the incorporation of 35S-
methionine and -cystein into newly synthesized β-actin
during a brief time period (30 min), immediately followed
by immunoprecipitation using anti-β-actin monoclonal
antibody. This experiment reveals an enhanced translation
of β-actin in the TIA-knocked down HeLa cells, whereas
translation of the α-tubulin protein was unchanged be-
tween the two groups (Figure 2D). Taken together, these
results suggest that TIA proteins regulate β-actin produc-
tion by modulating β-actin mRNA translation.
TIA proteins associate with β-actin mRNA through
3′-untranslated region
Next, we tested the interaction of TIA proteins with the
mRNA encoding human β-actin. By ribonucleoprotein
immunoprecipitation analysis from cytoplasmic extracts
from HeLa cells, β-actin mRNA was significantlyenriched in TIA1, TIAR and HuR immunoprecipitation
compared with TIA1 plus RNase A treatment, U2AF65
and the beads (Figure 3A). To find out the putative RNA
sequences of binding we used the information maps for
TIA proteins generated by Ule’s group using in vivo
ultraviolet cross-linking and immunoprecipitation (iCLIP)
analysis [9]. The RNA map of TIA proteins for ACTB
pre-mRNA suggests that the prevalent RNA region to
bind these proteins could be located on the 3′-untrans-
lated region (UTR) of the β-actin mRNA (Figure 3B and
Additional file 2: Figure S2). Before to test this possibility,
we analyzed the putative heterogeneity of this RNA se-
quence using several different strategies, such as RT-PCR,
RACE and RLC combined with poly (A) test (PAT) ana-
lysis (Additional file 3: Figure S3). The results suggested
that the 3′-UTR region of human β-actin mRNA between
two examined groups of HeLa cell lines is identical
(Additional file 3: Figure S3). It was previously shown that
β-actin mRNA associates with the HuR protein with high
affinity and specificity on 3′-UTR RNA sequences of this
messenger [29]. To determine whether the TIA1 and
TIAR proteins bind also this region of β-actin mRNA, we
performed electrophoretic mobility shift assays using the
Figure 2 Permanent TIA depletion improves β-actin mRNA translation. (A and B) Western blotting and reverse transcription-real time PCR
(RT-QPCR) analysis showing knockdown efficiencies of control (c, white bars), TIA1 (1, lightgray bars), TIAR (R, darkgray bars), TIA1 plus TIAR (1 + R,
black bars) and HuR (H, gray bars) and their effects on β-actin protein expression and mRNA levels. (C) Polysome profiling analysis using sucrose
gradients from control (c, white bars) and TIA1 plus TIAR (1 + R, black bars)-knocked down HeLa cells. The quality of polysome preparation was
verified by electrophoresis analysis in TBE-2% agarose gels of RNA content in each fraction. Ribosomal 5S, 18S and 28S bands are shown. Density
distribution of relative translational efficiencies of β-actin and GAPDH mRNAs was verified by semiquantitative and QPCR analysis, respectively, in
fraction pools identified as free-monosomes (FM) (fractions 1-7) and polysomes (fractions 8-11). Data are the mean ± SEM from two independent
analysis. The represented values (A-C) were normalized and are expressed relative to control (c), whose value is fixed arbitrarily to 1. (D) Nascent
translation of total, β-actin and α-tubulin proteins was determined by incubation of control (c) and TIA1 + TIAR (1 + R)-silenced HeLa cells in the
presence of 35S-methionine/cystein mix. After immunoprecipitation using anti-β-actin, anti-α-tubulin and IgG (negative control) antibodies, the
newly translated proteins were visualized by 10% SDS-PAGE and autoradiography. In all indicated cases, molecular weight markers for protein or
DNA and the identities of proteins and amplified PCR products are shown.
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and the recombinant GST-tagged TIA1 and TIAR proteins
as well as recombinant MBP-tagged HuR protein. When
these proteins were incubated with the full-length RNA
probe, similar RNA-binding complexes were observed
(Figure 3D, lanes 2-13). However, GST alone did not form
any complex with this probe (Figure 3D, lane 1). These re-
sults suggest that TIA proteins, like HuR protein, can bind
human 3′-UTR RNA of β-actin mRNA with a similar af-
finity. To confirm the iCLIP data (Figure 3B) and to know
if the individual sequences on β-actin 3′-UTR (Figure 3C,
see U-rich stretches underlined on probes 1-3) are theprevalent sites where TIA proteins interact with this RNA,
the full-length β-actin mRNA 3′-UTR was divided in four
portions (probes 1-4 in Figure 3E and F). When the four
probes were incubated with recombinant versions of
TIA1, TIAR and HuR proteins, irradiated with ultraviolet
light and treated with RNase A, an RNA-binding complex
was observed with the probes 1 and 3 but not with the
others (Figure 3E and F). All these data, combined with
the previous TIA-iCLIP findings, suggested that TIA pro-
teins could interact with the 3′-UTR of β-actin mRNA.
To test if the interaction of TIA proteins with the β-
actin 3′-UTR was functional, we prepared reporter
Figure 3 TIA proteins bind to the human β-actin mRNA 3′-UTR. (A) TIA and HuR proteins interact with β-actin mRNA. HeLa extracts were
incubated with anti-TIA1 (in the absence or presence of RNase A), anti-TIAR, anti-HuR and anti-U2AF65 antibodies. Immunoprecipitated RNAs were
isolated and quantified the β-actin mRNA levels by semiquantitative RT-PCR. The resulting PCR products were analyzed by 2% agarose-electrophoresis.
In lane 1 (indicated as c above legend), 1/10 of the HeLa extract used in immunoprecipitation assays was amplified by RT-PCR. As a negative control,
the beads were used (lane 7). (B) RNA map of TIA proteins on human β-actin (ACTB) gene by iCLIP analysis. Crosslinking sites of TIA1 and TIAR on the
human β-actin gene in HeLa cells. The bar graph shows the number of cDNAs that identifies each crosslinking site [9]. Note that the highest density of
crosslinking sites of the TIA1 and TIAR proteins is located at the 3′-UTR of the β-actin mRNA (for more details see Additional file 2: Figure S2).
(C) Nucleotide sequence of the 3′-UTR of the human β-actin mRNA (NM_001101.3). The full-length sequence of the β-actin 3′-UTR was divided to
generate four probes. In the probes 1 and 3, the major sites bind TIA proteinswere underlined. (D) RNA band shift assays of TIA proteins to β-actin
3′-UTR. Electrophoretic mobility shift assays were performed incubating GST (500 ng), GST-TIA1, GST-TIAR and MBP-HuR (0, 10, 100, 500 and 1000 ng)
proteins with 32P-labeled β-actin 3′-UTR RNA. (E and F) Ultraviolet crosslinking assays illustrating the direct interaction between TIA1, TIAR or HuR
proteins and β-actin 3′-UTR RNA probes. The F and P1-P4 legends correspond to full-length β-actin 3′-UTR RNA and the four β-actin RNA probes
indicated in C, respectively. Molecular weight markers and the identities of protein-RNA complexes are shown.
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entire human β-actin 3′-UTR was inserted after of the
GFP coding region. The corresponding control pEGFP-
C1 was generated by direct mutagenesis inserting a stop
codon to produce the same GFP protein above. After
transfections of each reporter construct into HeLa cells
expressing control (empty shRNA) or knocked down
TIA and HuR proteins (TIA1, TIAR or HuR shRNAs),
GFP expression was assessed by western blotting
(Figure 4A). As observed, the knockdown of TIA pro-
teins selectively increased GFP production in pEGFP-C1-β-actin 3′-UTR, but not significantly in controls.
This increase in GFP protein did not arise from changes
in GFP mRNA (Figure 4A). In the same vein, to test if
the interactions of TIAR and HuR with the β-actin 3′-
UTR were functional, we co-transfected the previous
pEGFP-C1 and pEGFP-C1-β-actin 3′-UTR constructs in
the absence or presence of TIAR- and HuR-tagged
pEGFP-C1 plasmids (Additional file 4: Figure S4). As ob-
served, the over-expression of TIAR selectively decreased
GFP production, but not in the control (empty plasmid)
and HuR reporter groups (Additional file 4: Figure S4,
Figure 4 The ablation of TIA1 gene in murine embryonic fibroblasts increases the expression of mouse β-actin protein without affecting
the levels of mRNA. (A) A chimeric GFP RNA containing β-actin 3′-UTR reproduces the regulation of the endogenous human β-actin mRNA in control
(c), TIA1, TIAR and HuR-knocked down HeLa cells. The relative expression levels of GFP protein versus endogenous α-tubulin levels as well as the levels
of reporter GFP mRNAs versus endogenous GAPDH mRNA were quantified by western blot analysis and QPCR, respectively. The quantifications are
represented by histograms where white and black bars correspond to the GFP protein/RNA expression from GFP and GFP-β-actin 3′-UTR transfected
plasmids, respectively. (B) Effect of the disruption of mouse TIA1 gene on β-actin expression in murine embryonic fibroblasts (MEF). Protein extracts
and cytoplasmic RNAs from normal murine embryonic fibroblasts (WT MEFs) or knocked out for TIA1 (TIA1 KO MEFs) were purified and processed for
western blot analysis with anti-β-actin, anti-TIA1, anti-TIAR, anti-HuR, anti-U2AF65 and anti-α-tubulin antibodies, or for QPCR analysis with mouse β-
actin and GAPDH specific-mRNA primers, respectively. Molecular weight markers for protein (kDa) are indicated on the left. The identities of protein
bands are indicated on the right by arrowheads. The represented values by histograms were normalized and are expressed relative to control (c),
whose value is fixed arbitrarily to 1.
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these results suggest that TIA and HuR can regulate
translation and/or stability of β-actin mRNA.
The disruption of TIA1 gene in murine embryonic
fibroblasts leads to an increase in the expression of
β-actin protein without changes in the mRNA levels
The above results support a role for TIA proteins in the
post-transcriptional modulation of human β-actin
mRNA expression exerted through its 3′-UTR. Given
the high degree of conservation between human and
mouse 3′-UTR sequences (Additional file 5: Figure S5),
we decided to examine the potential effects of TIA1
protein on β-actin protein expression as well as the de-
gree of regulatory conservation of post-transcriptional
mechanisms between men and mice. For this purpose,
endogenous β-actin protein and mRNA levels werecompared in two fibroblast cell lines of mouse [1]: (i) a
wild-type mouse fibroblast cell line (WT MEF) and (ii) a
mutant cell line in which the two copies of the TIA1
gene had been knocked out (TIA1 KO MEF). Western
blot analysis showed that β-actin expression level is
increased approximately 2-fold in TIA1 KO MEF com-
pared to WT MEF (Figure 4B); despite the levels of α-
tubulin and U2AF65 protein being lower in TIA1 KO
MEF cells than in the wild-type culture. No differences
in the expression level of HuR protein was detected in
the mouse cell types examined (Figure 4B). The aug-
mented expression of β-actin protein in TIA1 KO MEF
cells is not due to the state-steady levels of β-actin
mRNA because similar abundance of β-actin mRNAs
was found by quantitative RT-PCR in the two mouse cell
lines (Figure 4B). Thus, MEFs with TIA gene disruption
show an increased level of β-actin as previously observed
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function in both HeLa and MEFs suggests that they dis-
play a master regulator function in β-actin expression.
Discussion
Our results support that a sustained knockdown of
TIA1 and TIAR proteins in HeLa cells and the gene ab-
lation of TIA1 in mouse embryonic fibroblasts leads to
increased expression of β-actin protein without signifi-
cant changes at the steady-state levels of the β-actin
mRNA. These observations are consistent with a transla-
tional modulation of β-actin mRNA and the binding of
TIA proteins on the β-actin mRNA through its 3′-UTR.
This finding is coherent with the RNA map (iCLIP ana-
lysis) of interactions among β-actin mRNA and TIA1/
TIAR proteins described by Ule’s group [9]. By contrast,
it was unexpected to find that TIA proteins may be
involved in the translation of the β-actin mRNA, since
transient knockdown of these regulators did not affect
its translational efficiency [21,22 and Additional file 6:
Figure S6]. Thus, it is possible that the binding to long
U-rich stretches both in TIA and HuR proteins could re-
press and/or stabilize β-actin mRNA in response to dy-
namic behaviors of gene regulatory networks associated
with environmental stresses. This association might be
stable and compensatory throughout during the life span
of the cell, but it could be altered by the permanent defi-
ciency of some specific RNA binding proteins and/or
RNAs as, for example, microRNAs and/or non-coding
RNAs.
The actin proteins in the cell of higher eukaryotes are
encoded by six individual genes [30]. The global features
of these protein products are their ubiquitous distribu-
tion, stability and high concentration. The expression of
actin genes is regulated at the transcriptional level [31].
However, regulatory post-transcriptional events such as
the cellular localization, stability and translation of their
mRNAs affect where and how these proteins will be syn-
thesized in the cell [32-39]. The specific localization of
each protein isoform corresponds to the precise and
exact distribution of their mRNAs which are targeted for
translation [33-35]. The selective localization, stability
and/or translation of the β-actin mRNAs is regulated by
the collaboration of a specific bipartite sequence in the
3′-UTR and the zip code-binding protein (ZBP) [36-39].
This regulatory event is a paradigm to understand the
relevance of localization, movement, motility of cellular
mRNAs to generate selective distribution, targeting and
expression of proteins in order to promote functional
heterogeneity to participate in the formation and main-
tenance of important cellular structures such as extracel-
lular matrix, stress fibers and lamellipodia [40-42].
Stability/turnover and translation of eukaryotic mRNAs
are two sides of the same coin from a strictly regulatoryviewpoint of the expression gene at the post-transcriptional
level. Given that TIA proteins, like HuR protein, are
known to stabilize and/or to translational repress/activate
mainly short-lived mRNAs (for example mRNAs encoding
cytokines, lymphokines, protooncogenes and growth fac-
tors) that are required for cell differentiation/proliferation,
inflammation or apoptosis [1,8,9,15-17]. These cellular
mRNAs are quickly translated and/or degraded because it
is crucial a limited concentration of their products to pro-
tect the cell from undesirable effects, as for example an
uncontrolled growth. The TIA-iCLIP analysis in HeLa
cells previously showed that highest enrichment density of
cDNAs were seen in introns and 3′-UTRs [9]. These ob-
servations are consistent with the role of TIA proteins in
pre-mRNA splicing, stability and/or translational regula-
tion via binding U-, C- and AU-rich sequence elements lo-
cated at the 5′ spliced sites and 3′-UTRs, respectively
[1,7,9,14,15,17,19,20]. It is interesting that no overlap was
observed between gene targets reported to be regulate by
TIA1 at the translational level [19] and genes predicted to
be regulated by TIA1/TIAR at the alternative pre-mRNA
splicing level [14]. This observation suggests that TIA
proteins could be regulating distinct subsets of genes at
the splicing and translational levels. The TIA-iCLIP data
have expanded the total number of post-transcriptional
events and associated gene functions that could be pre-
dicted to be regulated by TIA proteins. Thus, the esti-
mated frequency of cellular events regulated by TIA1/
TIAR via specific-sequences motifs might be approxi-
mately 20-30% [9,14].
The mechanism of TIA-induced translational repres-
sion has been partially characterized for conditions of
environmental stress such as oxidation and nutrient
deprivation responses. For example, under oxidative
conditions eIF2α phosphorylation inhibits translation
initiation and TIA proteins contribute to the assembly of
unproductive translation pre-initiation complexes with
the mRNA to stress granules [43]. When cellular scenario
is upon amino acid starvation, TIA proteins assemble onto
the 5′ end of the 5′-terminal oligopyrimidine tracts (5′-
TOP) mRNAs and arrest translation at the initiation step.
The TIA-dependent 5′-TOP mRNA translation repression
implies polysomal release and accumulation in stress
granules [21]. This repressor activity requires starvation-
mediated activation of the GCN2 (general control non-
derepressible 2) kinase, which could be activated by the
accumulation of unchanged tRNAs, and inactivation of
the mTOR (mammalian target of rapamycin) signalling
pathway [21], although this is a controversial issue [22].
These observations could explain limitedly how large net-
works of cellular RNAs encoding protein biosynthesis fac-
tors can be post-transcriptional co-regulated in response
to nutrient availability by specific RNA binding proteins
as TIA proteins.
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cell lines produced larger and faster-growing tumors fol-
lowing injection in nude mice [27]. Further, we have de-
scribed that TIA protein expression levels decrease in
many cancer cell lines [44] and some human tumor
types [27], suggesting that TIA proteins might play a
relevant role as suppressor genes of cell proliferation
and tumor growth. It is now well established that a main
feature of cancer cells is uncontrolled proliferation. An
increased expression level of β-actin protein is required
for relevant biological processes involving from cell
shape, growth to the motility, because β-actin is a major
component of the cytoskeleton in non-muscle cells
[28,42]. Therefore, this raises the possibility that the per-
manent reduction of the TIA proteins in several cancer
cells improves the expression of the β-actin protein,
which in turn modifies cytoskeleton organization and
cellular functions/phenotypes.
Conclusions
The aim of this study was to investigate how the per-
manent down-regulation of the T-cell intracellular anti-
gens (TIA1 and TIAR) leads to the uncontrolled cellular
growth phenotypes. Consistent data are provided dem-
onstrating that these effects are due, at least in part, to
the increased expression of the β-actin (ACTB) that,
consequently, promotes the assembly of cytoskeletal
stress fibers. Given that the steady-state levels of the
ACTB mRNA remained unchanged under these condi-
tions, the results suggested that TIA proteins may be
regulating the translation of the ACTB mRNA. By asses-
sing the steady-state levels of the ACTB mRNA on
monosomal and polysomal fractions purified by sucrose
gradients and by immunoprecipitating of metabolically-
labeled ACTB protein in control and TIA-down-
regulated HeLa cells, TIA proteins can modulate the
translation of the ACTB mRNA. Immunoprecipitation
of ribonucleoprotein complexes coupled to RT-PCR ana-
lysis, electrophoretic mobility gel shift assays and qui-
meric RNA transfections pointed out the potential
binding of TIA1/TIAR proteins with ACTB mRNA in a
3′-UTR-dependent manner. Additionally, the expression
of the ACTB protein was greater in mouse embryonic fi-
broblasts (MEF) knocked-out for TIA1 than control
MEF. Taken together, these observations support that
sustained reduction of TIA proteins enhances expression
of ACTB protein, suggesting a role for TIA proteins as
repressors of ACTB mRNA translation.
Methods
Cell cultures, plasmids and recombinant proteins
Adherent HeLa cell lines expressing stably empty (con-
trol), TIA1 and/or TIAR, and HuR shRNA-pSUPER con-
structs were cultured under standard conditions aspreviously reported [27]. Murine embryonic fibroblasts
(MEFs) wild-type and knocked out for TIA1 were gener-
ated and grown as described [1,45]. The 3′-UTR se-
quence from the human β-actin mRNA was generated
by RT-PCR from cytoplasmic RNA or by PCR from gen-
omic DNA purified of HeLa cells by using reverse tran-
scriptase (Promega) and/or Pfu Turbo DNA polymerase
(Stratagene), respectively. The construct used to test the
translational efficiency of human β-actin 3′-UTR RNA
was generated by subcloning the corresponding PCR
product to the carboxy-terminal part of GFP using vec-
tor pEGFP-C1 (Clontech). In this construct, as well as
control GFP-plasmid, was introduced a stop codon by
direct mutagenesis expressing a truncated version of
GFP lacking the last 18 amino acids at the carboxy ter-
minal end. The sequences of all constructs were verified
by automated DNA sequencing. Recombinant GST, TIA1,
TIAR, and HuR proteins were expressed in Escherichia
coli, purified as glutathione-S-transferase (GST) or
maltose-binding protein (MBP) fusions using glutathione-
Sepharose (Sigma) or amylose resin (BioLabs), respect-
ively, and stored in buffer D (20 mM Hepes, pH 7.6, 20%
glycerol, 0.2 mM EDTA, 1 mM DTT, and 0.01% NP-40)
plus 0.1 M KCl at -70°C until used [46].
Fluorescence microscopy
The different HeLa cell lines were grown for 24 h on
coverslips and processed as previously described [47].
Endogenous TIA1/TIAR/HuR/β-actin/α-tubulin-antibody
complexes, TO-PRO-3, or phalloidin-stained proteins
were viewed by confocal microscopy. The quantification
of relative fluorescence intensity corresponding to the
used molecular markers was carried out using ImageJ soft-
ware. The results shown in the corresponding histograms
are average of at least independent 30 images for each
condition examined.
Protein analysis and RNA isolation
Whole-cell HeLa extracts were prepared by resuspend-
ing the cells in lysis buffer (50 mM Tris–HCl, pH 8.0,
140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet P-40 plus
a cocktail of protease inhibitors), freeze-thawing 3 times,
and centrifugation at 10,000 rpm for 10 min in a micro-
fuge at 4°C. The supernatants were recovered and stored
at −70°C. Protein concentration was determined with
the Bradford reagent (Bio-Rad). Western blots were car-
ried out using nylon membranes and the following anti-
bodies: anti-β-actin (AC-74, Sigma), anti-TIA-1 (C-20,
Santa Cruz Biotechnology), anti-TIAR (C-18, Santa Cruz
Biotechnology), anti-HuR (3A2, Santa Cruz Biotechnol-
ogy), anti-GFP (JL-8, BD Biosciences Clontech), and
anti-α-tubulin (B-5-1-2, Sigma). The blots were devel-
oped using ECL reagent (Amersham Pharmacia Biotech).
Cytoplasmic RNAs were prepared using the RNeasy kit
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density at 260 nm and treated with RNase-free DNase
(Promega). For QPCR, an aliquot (5 ng) of the cDNAs
and 0.5 μM of each primer together with Power Sybr
Green PCR Master mix (Applied Biosystems) were used
following the protocol: 10 min at 95°C followed by 20–
40 cycles of denaturation (15 s at 95°C) and annealing–
elongation (1 min at 60°C) with fluorescence acquisition
at 60°C. A melting curve (15 s at 95°C, 15 s at 60°C, and
15 s at 95°C) with fluorescence acquisition at 60–95°C
was included in each qPCR. An aliquot (1/10) of the
cDNAs was amplified by QPCR using, GFP- and
GAPDH-specific oligonucleotide pairs [8]. The amplifi-
cation efficiency of each primer was empirically deter-
mined and applied to the relative quantification of the
data using qbase software (http://medgen.ugent.be/qbase/).
In semiquantitative RT-PCR analysis, RNA was reverse-
transcribed using β-actin mRNA 3′-UTR-specific primers
and AMV reverse transcriptase (Promega) for 1 h at 42°C
[8]. After 25 cycles, the products were analyzed on 2%
agarose gels.
Polysome profiling analysis using sucrose gradients
Two independent p100 plates of subconfluent HeLa cells
with control or TIA1 + TIAR reduced expression were
used in this study. Five minutes before lysis, cells were
incubated with 50 μg/ml of cycloheximide (CHX) to
freeze the polysomes. Cells were washed twice with cold
PBS-CHS and lysed in polysome buffer (Hepes 30 mM
pH 7.4, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 1% Tri-
ton X-100) supplemented with 0.5 mg/ml of heparin and
50 μg/ml of cycloheximide. After 15 min of incubation,
cells were centrifuged at 8,000×g in a microfuge at 4°C.
Supernatant was immediately loaded on ultracentrifuge
tubes containing a 15-40% sucrose gradient in polysome
buffer. Gradient were spun at 39,000 rpm for 2 h in a
SW40 rotor (Beckman) at 4°C. Tubes were fractionated
from the top to get 11 fractions that were extracted im-
mediately with phenol:chloroform and precipitated with
sodium acetate, 2 volumes of ethanol and glycoblue
(Ambion) overnight at -70°C. An aliquot (1/10) of the
RNA content of each fraction RNA was analyzed by 2%
agarose-TBE electrophoresis. Fractions from 1 to 7 (free
plus monosome) and from 8 to 11 (polysome) were
pooled and precipitated with LiCl overnight at -20°C.
The RNA pellet was washed with 70% ethanol and re-
suspended in lysis buffer of RNeasy kit (Qiagen) and
purified according to the manufacturer’s instructions.
Immunoprecipitation of metabolically labeled proteins
and immunoprecipitation-RT-PCR (IP-RT-PCR) analysis
Anti-β-actin, anti-α-tubulin or anti-IgG antibodies were
added to 20 μl of cytoplasmic extracts from control (c)
and TIA1/TIAR (1 + R)-knocked down HeLa cellsincubated with 1 ml methionine-cysteine free DMEM
supplemented with 5 μl Easy Tag™ EXPRESS 35S Protein
Labeling mix, [35S] Met-Cys (11 mCi/ml, 37.0 Tbq/
mmol; Perkin Elmer) for 30 min, complemented with
buffer D to a total volume of 25 μl and incubated for 1 h
on ice. After addition of 20 μl of protein G-Sepharose
beads (1/1) and 40 μl of IPP 100 buffer (10 mM Tris
pH 8.0, 100 mM NaCl, 0.1% NP-40), the reaction was in-
cubated for 1 h on a rotating wheel at 4°C. The beads
were collected at 1,000 rpm and washed four times with
ice-cold IPP 100 buffer. A 2 μl aliquot of each sample
was removed as loading control. The immunoprecipi-
tated antibody-protein complexes were released from
the agarose beads by boiling in Laemmli sample buffer
and analyzed by 10% SDS–PAGE and autoradiography.
For IP-RT-PCR assays, β-actin mRNA was coimmuno-
precipitated from HeLa cell extracts prepared by the
Lejeune and Maquat method [48] in NET-2 buffer
(50 mM Tris–HCl, pH 7.4; 300 mM NaCl; 0.05% NP-40
plus a cocktail of protease inhibitors). Antibodies against
TIA1, TIAR, HuR, U2AF65 or alone beads and 200 U of
RNase inhibitor (Promega) were added to whole-cell ex-
tracts, and the samples incubated for 1 h at 4°C using
end-over-end rotation. Protein G agarose beads (50 μl),
previously incubated with yeast RNA for 1 h at 4°C,
were added and the samples incubated for 1.5 h at 4°C
and washed five times with 1 ml NET-2 buffer. RNA as-
sociated with the antibody–antigen complexes was
eluted with sample buffer (0.1 M Tris–HCl, pH 6.8; 4%
SDS; 12% β-mercaptoethanol; 20% glycerol), extracted
with phenol:chloroform, precipitated with sodium acetate
plus glycoBlue (Ambion) and ethanol, treated with DNase,
and finally analyzed by semiquantitative RT-PCR.Poly (A) test (PAT) assays
Reverse transcription and polymerase chain reaction
with PAT (RT-PCR-PAT), rapid amplification of cDNA
ends PAT (RACE-PAT) and RNA-ligation coupled PAT
(RLC-PAT) were carried out as described previously [49].Preparation of in vitro synthesized RNA probes,
electrophoretic mobility shift assays (EMSA) and
ultraviolet crosslinking (UV-CXL) analysis
In vitro transcription reactions were performed with T7
RNA polymerase from PCR template as described previ-
ously [46]. EMSA and UV crosslinking assays were car-
ried out as previously described [46] using 100,000 cpm
of 32P-labeled RNAs and the purified recombinant
fusion proteins indicated in the Figure legends. The
RNA-protein binding reaction was carried out in a total
volume of 10 μl of buffer D containing 100 mM KCl and
3 μg of yeast tRNA. The 32P-labeled RNA-protein com-
plexes were fractionated on 5% native PAGE gel for
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ized by autoradiography.
Additional files
Additional file 1: Figure S1. RNAi-mediated knockdown on TIA and
HuR proteins in HeLa cells. (A) HeLa cells were transfected with empty
plasmid or plasmids expressing shRNAs against TIA1, TIAR or HuR mRNAs.
The resulting stable HeLa cell lines were stained with anti-TIA1, anti-TIAR,
anti-HuR and anti-α-tubulin antibodies. The fluorescence intensity of ΤΙΑ1,
TIAR, HuR and α-tubulin were quantified at least 30 different images per
sample using ImageJ software. These quantifications are represented by
histograms where the white, lightgray, darkgray, black and gray bars
correspond to the control, TIA1, TIAR, TIA1 plus TIAR (1 + R) and HuR
samples, respectively. The represented values were normalized and
expressed relative to control (c), whose value is fixed arbitrarily to 1, and
are means ± SEM (n = 30). The scale bar shows 8 μm.
Additional file 2: Figure S2. Crosslinking sites (iCLIP) of TIA1 and TIAR
proteins at 3′-UTR of the human β-actin mRNA. The RNA map corresponding
to TIA proteins on β-actin pre-mRNA in HeLa cells was adapted using the
TIA-iCLIP analysis provided by Jernej Ule’s laboratory [9]. The bar graphs
show the number of cDNAs that identified each crosslinking site. The exon
and intron positions of the human β-actin (ACTB) pre-mRNA are indicated.
The full-picture of the TIA-iCLIP analysis on human β-actin 3′-UTR sequence
is shown at the nucleotide level.
Additional file 3: Figure S3. Characterization of the human 3′-UTR of
β-actin mRNA by poly (A) test (PAT) assays. (A-C) Reverse transcription
and polymerase chain reaction with PAT (RT-PCR-PAT) (A), rapid
amplification of cDNA ends PAT (RACE-PAT) (B) and RNA-ligation coupled
PAT (RLC-PAT) (C) are shown. These PAT assays were carried out as
previously described [49]. The results suggest that 3′-UTR heterogeneity
(size and polyadenylation degree) of human β-actin mRNA is similar in
control and TIA1/TIAR (1 + R)-knocked down HeLa cells. Molecular weight
markers for DNA are indicated on the left. The identities of DNA bands
are indicated on the right by arrowheads.
Additional file 4: Figure S4. Ectopic expression of GFP-tagged TIAR
inhibits the translation of a chimeric GFP RNA containing human 3′-UTR.
Western blot analysis of HeLa cell extracts (10 μg) prepared 24 h post-
transfection with a control plasmid (c) or plasmids expressing GFP-
tagged TIAR or HuR proteins together with either GFP or GFP-β-actin 3′-
UTR reporter plasmids. The represented values by histograms were
normalized and are expressed relative to control (c), whose value is fixed
arbitrarily to 1, and are means ± SEM (from two independent analysis).
Molecular weight markers for protein are indicated on the left. The
identities of protein bands are indicated on the right by arrowheads.
Additional file 5: Figure S5. Multiple alignment of 3′-UTR sequences of
human and mouse β-actin mRNAs. The nucleotide sequences corresponding
to the 3′ UTR of human and mouse β-actin mRNAs were aligned using
ClustalW program. The NCBI nucleotide accession numbers of human and
mouse β-actin mRNAs are indicated as follows: Homo sapiens: NM_001101.3
and Mus musculus: NM_007393.3. Observe the high degree of conservation
of uridine-rich sequences downstream from stop codon. Conservation is also
observed towards the center and 3′-end of the 3′-UTRs. Stop codons, U-rich
sequence elements and polyadenylation signals are underlined and
coloured.
Additional file 6: Figure S6. Transient depletion of TIA proteins in
HeLa cells did not alter β-actin protein expression. (A) Positions and
sequences of the siRNAs used for RNA interference of TIA1 and TIAR.
Location refers to positions of the first and last nucleotides in full-length
cDNAs. As control siRNA was used a non-silencing siRNA duplex fluorescein
labeled 27-6411-02FL from Gene Link. (B) Western blot analysis of HeLa cell
extracts (2 μg (lane 1; c (1/5)) or 10 μg (lanes 2 to 4) prepared 72 h after
transfection with siRNAs against control (c, lanes 1 and 2) and TIA1 plus TIAR
(lanes 3 and 4; 1 + R). The transient knockdown of TIA1 and TIAR protein
levels was approximately 70-80% under these conditions. The blot was
probed with antibodies against TIA1, TIAR, HuR, β-actin and α-tubulin
proteins, as indicated. Molecular weight markers and the identities of
protein bands are shown.Abbreviations
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